Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719146 · ClinicalTrials.gov registry record
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 134
- Enrollment target
NCT01719146 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 134 participants.
The verdict
NCT01719146 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
The purpose of this study is to prospectively collect data on doses of Erythropoietic Stimulating Agents (ESA) and Intravenous Iron, and the markers of erythropoietic activity and iron status. These data will be used to derive mathematical models which will subsequently guide dosing of both agents, such that a desired therapeutic outcome is achieved in every patient, while minimizing patient exposure to both agents.
Interventions
- OTHER Specimen collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2013-01 |
| Est. Completion | 2021-06-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01719146
The ClinicalTrials.gov registry entry for NCT01719146 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Specimen collection is the first listed.
NCT01719146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01719146 about?
NCT01719146 is a clinical study titled "Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease". The purpose of this study is to prospectively collect data on doses of Erythropoietic Stimulating Agents (ESA) and Intravenous Iron, and the markers of erythropoietic activity and iron status. These data will be used to derive mathematical models which will subsequently guide dosing of both agents, ...
What is the current status of trial NCT01719146?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2013-01. Estimated completion is 2021-06-05.
What interventions are being tested in trial NCT01719146?
The interventions under investigation include: Specimen collection (OTHER).
Who is sponsoring clinical trial NCT01719146?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.